Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ardent Health, Inc. due to allegations of violations of federal securities laws related to misleading statements about the company's accounts receivable and professional malpractice liability insurance [4][6]. Group 1: Legal Investigation and Class Action - The firm is reminding investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against Ardent [4]. - The complaint alleges that Ardent and its executives made false statements and failed to disclose critical information regarding the company's financials [6]. - Investors who suffered losses from purchasing Ardent securities between July 18, 2024, and November 12, 2025, are encouraged to contact the firm for legal options [1][4]. Group 2: Financial Impact and Stock Performance - On November 12, 2025, Ardent announced a $43 million reduction in revenue and a $54 million increase in professional liability reserves due to accounting changes [6]. - Following this announcement, Ardent's stock price fell by $4.75 per share, or 33.81%, closing at $9.30 per share on November 13, 2025 [7]. Group 3: Additional Information and Contact - Faruqi & Faruqi encourages anyone with information regarding Ardent's conduct, including whistleblowers and former employees, to reach out [9]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [5].
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health